Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Berardinelli-Seip congenital lipodystrophy"
Show Display Options
Rank Status Study
1 Active, not recruiting Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Conditions: Hypoleptinemia;   Generalized Lipodystrophy;   Partial Lipodystrophy;   Insulin Resistance
Interventions: Drug: Leptin;   Drug: Placebo
2 Enrolling by invitation Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Conditions: Lipodystrophy;   Diabetes;   Hyperlipidemia
Intervention: Drug: Metreleptin
3 Active, not recruiting Leptin to Treat Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: Metreleptin

Indicates status has not been verified in more than two years